Published : 12 Sep 2019
Aagami has been appointed by a new client to help out-license their on the market drug as well as other assets/ technologies in their extensive pipeline. The geographies assigned to Aagami for the project are the US, Japan, India and South Korea.
Client is a UK based pharma focused on increasing the availability of safe and effective specialty medicine. The client has already successfully brought two paediatric medicines and a further specialty medicine to market.
Aagami team look forward to finding the right licensing partners for the client and are excited about multiple deal possibilities to bring further success to the client.